However, there was no significant correlation between the prognosis of STAD patients and the expression of CD44 under the infiltration of CD4+ memory T cells, macrophages, regulatory T cells and type 2T-helper cells (Fig. 7). This evidence concerns the gene CD44 and gastric adenocarcinoma.